Supplementary Figure 1 from ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors

2026 Open access

Read full text
Authors: Jennifer D. Stone, Kamonwan Fish, Devika Ashok, Laura M. McKay, Saeed Salehin Akhand, Enrico L. DiGiammarino, Hector David Inzunza, Joann P. Palma, Cormac Cosgrove, Paul A. Ellis, David Peetz, Stephanie Shee
+4 more Adam S. Chervin, Claudina Stevenson, Tamar Uziel, Edward B. Reilly
DOI: 10.1158/0008-5472.31228594
Cited by: 0

Abstract

Activation of T cells in response to ABBV-303 within a PBMC mixture vs. purified.

Fields of Study & Subjects

Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research

Publication details

Publication date
2 February 2026